Dear Reader, We are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy reading it.
๐๐จ๐๐ญ๐จ๐ซ ๐ฐ๐ข๐ฅ๐ฅ ๐๐ ๐ฏ๐ข๐๐๐ซ๐ข๐จ๐ฎ๐ฌ๐ฅ๐ฒ ๐ฅ๐ข๐๐๐ฅ๐ ๐ญ๐จ ๐ฉ๐๐ฒ ๐๐จ๐ฆ๐ฉ๐๐ง๐ฌ๐๐ญ๐ข๐จ๐ง ๐๐ฏ๐๐ง ๐ข๐ ๐ก๐ข๐ฌ ๐๐๐ฏ๐ข๐๐ ๐ฐ๐๐ฌ ๐ฉ๐ซ๐จ๐ฉ๐๐ซ ๐๐ฎ๐ญ ๐ฐ๐๐ฌ ๐ง๐จ๐ญ ๐๐จ๐ฅ๐ฅ๐จ๐ฐ๐๐ ๐๐ฒ ๐ก๐จ๐ฌ๐ฉ๐ข๐ญ๐๐ฅ ๐ฌ๐ญ๐๐๐: ๐๐๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐จ๐ง๐ฌ๐ฎ๐ฆ๐๐ซ ๐๐จ๐ฆ๐ฆ๐ข๐ฌ๐ฌ๐ข๐จ๐ง
India’s apex consumer forum, the National Consumer Disputes Redressal Commission (NCDRC), has imposed a compensation of Rs. 30 Lakhs on a hospital and its doctors for deficiency in providing post operative care to patient. The NCDRC observed that failure to intubate the patient by hospital staff, including anaesthetist, despite the written advice of reintubation by the surgeon who had performed the surgery on the patient, amounted to medical negligence which left the patient in permanent vegetative state. The commission held that the surgeon was vicariously liable for the negligent actions of the hospital staff, along with the hospital.
Source: bit.ly/3THv6id
๐๐ซ๐ข๐๐ค ๐๐ง๐ ๐ฆ๐จ๐ซ๐ญ๐๐ฅ ๐ซ๐๐ญ๐๐ข๐ฅ ๐ฉ๐ก๐๐ซ๐ฆ๐๐๐ข๐๐ฌ ๐๐ซ๐ ๐ฉ๐ซ๐จ๐ฉ๐จ๐ฌ๐ข๐ง๐ ๐ญ๐จ ๐๐ซ๐๐๐ญ๐ ๐ฌ๐ข๐ง๐ ๐ฅ๐ ๐ฉ๐ซ๐จ๐๐ฎ๐ซ๐๐ฆ๐๐ง๐ญ ๐๐ง๐ญ๐ข๐ญ๐ฒ ๐๐ญ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ญ-๐ฅ๐๐ฏ๐๐ฅ ๐ข๐ง ๐๐๐๐ก ๐๐ญ๐๐ญ๐ ๐ญ๐จ ๐๐ ๐๐๐ฅ๐ ๐ญ๐จ ๐ฉ๐๐ฌ๐ฌ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ๐ฌ ๐ญ๐จ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐๐ซ๐ฌ, ๐๐ง๐ ๐๐จ๐ฎ๐ง๐ญ๐๐ซ ๐-๐ฉ๐ก๐๐ซ๐ฆ๐๐๐ข๐๐ฌ: ๐๐๐ฉ๐จ๐ซ๐ญ
India’s biggest association of brick and mortal retail pharmacies, The All India Organization of Chemists and Druggists (AIOCD), has reportedly proposed that it will guide its state branches to form a single entity, ‘distribution entity’ at every district or taluka level. AIOCD believes that having a single procurement and distribution entity will result in reduction of operational expenses, multiple licensing and tax payments for the unorganized distributors and chemists. It should also result in ability of retailers to pass more discounts to end consumers to ward-off the threat of e-pharmacies.
Source: bit.ly/43uy3G9
๐-๐ฐ๐๐ฌ๐ญ๐ ๐๐๐ ๐ช๐ฎ๐๐ซ๐ญ๐๐ซ๐ฅ๐ฒ ๐๐ง๐ ๐๐ง๐ง๐ฎ๐๐ฅ ๐ซ๐๐ญ๐ฎ๐ซ๐ง ๐๐ข๐ฅ๐ข๐ง๐ ๐ญ๐ข๐ฆ๐๐ฅ๐ข๐ง๐๐ฌ ๐ฆ๐๐ฒ ๐๐ ๐ซ๐๐ฅ๐๐ฑ๐๐
Indiaโs Ministry of Environment has notified the E-Waste (Management) Amendment Rules, 2024. The amendment has given the Ministry the power to relax the timelines for the filing of returns and reports by the manufacturer, producer, refurbisher or recycler, up to a period of nine months. As of now, the annual return filing date for manufacturers and producers of electrical and electronic equipment (EEE) is 30th April 2024.
Source: bit.ly/48Z5npS
๐๐๐ซ๐ค๐ข๐ง๐ ๐๐๐ ๐๐จ๐ซ ๐ฎ๐ฌ๐ ๐จ๐ ๐๐ง๐๐ข๐๐ง ๐๐ญ๐๐ง๐๐๐ซ๐ (๐๐) ๐ฆ๐๐ซ๐ค ๐ซ๐๐๐ฎ๐๐๐ ๐๐จ๐ซ ๐ฌ๐ญ๐๐ซ๐ญ-๐ฎ๐ฉ๐ฌ, ๐ฆ๐ข๐๐ซ๐จ, ๐ฌ๐ฆ๐๐ฅ๐ฅ ๐๐ง๐ ๐ฐ๐จ๐ฆ๐๐ง-๐ฅ๐๐ ๐๐ง๐ญ๐๐ซ๐ฉ๐ซ๐ข๐ฌ๐๐ฌ
Indiaโs Department of Consumer Affairs has recently introduced concessions for the annual minimum marking fee for use of Indian Standard (IS) mark. As per the revised Bureau of Indian Standards (BIS) (Conformity Assessment) Regulations 2018, micro-scale enterprises and startup enterprises will receive a concession of 80% against the prescribed annual marking fees as applicable to the particular product category, small-scale enterprises will receive a concession of 50%, and women-entrepreneur enterprises will receive an extra concession of 10%. These concessions are available until May 31, 2026.
Source: bit.ly/49MllVu
๐๐ฎ๐ฌ๐ญ๐ซ๐๐ฅ๐ข๐ ๐๐ซ๐๐ฐ๐ฌ ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ ๐๐๐ญ๐ฐ๐๐๐ง ๐๐๐ฏ๐๐ซ๐ญ๐ข๐ฌ๐ข๐ง๐ ๐ก๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐ฌ๐๐ซ๐ฏ๐ข๐๐๐ฌ ๐ญ๐ก๐๐ญ ๐ฎ๐ฌ๐ ๐ก๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐ฉ๐ซ๐จ๐๐ฎ๐๐ญ๐ฌ, ๐๐ง๐ ๐๐๐ฏ๐๐ซ๐ญ๐ข๐ฌ๐ข๐ง๐ ๐ก๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐ฉ๐ซ๐จ๐๐ฎ๐๐ญ๐ฌ
Australia’s drugs and cosmetics regulator, the Therapeutic Goods Administration (TGA), has prohibited direct or indirect references to prescription-only substances including terms such as โanti-wrinkle injections” and “derma fillers” by healthcare service providers such as hospitals. As per TGA, it should be clear in an advertisement for healthcare services that use healthcare products, such as cosmetic injection services, that the customer is being offered a health-practitioner-led consultation and that, depending on the outcome of the consultation, this may or may not lead to the provision of a prescription and injection.
Source: bit.ly/49O6Sbw